Hyperprogression under immunotherapy: a new form of immunotherapy response?-a narrative literature review

M.Z. Lin, B.G.L. Vanneste, Q.W. Yu, Z.B. Chen, J.Y. Peng, X.Y. Cai*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)3276-3291
Number of pages16
JournalTranslational Lung Cancer Research
Volume10
Issue number7
DOIs
Publication statusPublished - 1 Jul 2021

Keywords

  • Immunotherapy
  • hyperprogressive disease (HPD)
  • hyperprogression (HP)
  • CELL LUNG-CANCER
  • EVALUATION CRITERIA
  • DISEASE
  • GUIDELINES
  • CONTRIBUTES
  • PROGRESSION
  • BLOCKADE
  • THERAPY

Cite this